Correction: Cryopreservation of unrelated donor hematopoietic stem cells: the right answer for transplantations during the COVID-19 pandemic? - Takeaways - MDSpire

Correction: Cryopreservation of unrelated donor hematopoietic stem cells: the right answer for transplantations during the COVID-19 pandemic?

  • By

  • Jesus Fernandez-Sojo

  • Carmen Azqueta

  • Elena Valdivia

  • Lluis Martorell

  • Laura Medina-Boronat

  • Nuria Martínez-Llonch

  • Silvia Torrents

  • Margarita Codinach

  • Carme Canals

  • Izaskun Elorza

  • Rocio Parody

  • Rodrigo Martino

  • Maria Trabazo

  • Cristina Díaz de Heredia

  • Christelle Ferra

  • David Valcárcel

  • Mónica Linares

  • Águeda Ancochea

  • Enric García-Rey

  • Nadia García-Muñoz

  • Laura Medina

  • Nerea Castillo

  • Enric Carreras

  • Juliana Villa

  • Sergio Querol

  • May 28, 2024

  • 0 min

Share

  • 1

    The article discusses the cryopreservation of unrelated donor hematopoietic stem cells.

  • 2

    It addresses the relevance of this method during the COVID-19 pandemic.

  • 3

    A correction was made regarding the author's affiliation.

  • 4

    The affiliation of Jesus Fernandez-Sojo was missing in the original publication.

  • 5

    The corrected article was published online on June 14, 2021.

Original Source(s)

Correction: Cryopreservation of unrelated donor hematopoietic stem cells: the right answer for transplantations during the COVID-19 pandemic?

  • by Jesus Fernandez-Sojo, Carmen Azqueta, Elena Valdivia, Lluis Martorell, Laura Medina-Boronat, Nuria Martínez-Llonch, Silvia Torrents, Margarita Codinach, Carme Canals, Izaskun Elorza, Rocio Parody, Rodrigo Martino, Maria Trabazo, Cristina Díaz de Heredia, Christelle Ferra, David Valcárcel, Mónica Linares, Águeda Ancochea, Enric García-Rey, Nadia García-Muñoz, Laura Medina, Nerea Castillo, Enric Carreras, Juliana Villa, Sergio Querol

  • May 28, 2024

Related Content

Digitally Assessed Long COVID Symptomatology Is Associated With Lymphocyte Mitochondrial Dysfunction and Altered Immune Potential

Engagement of chymase-positive mast cells in myocardial damage associated with COVID-19

AI Scribes: Efficiency for Whom?

Unresolved safety, privacy, and regulatory concerns may limit benefits of AI scribes for physicians and patients.